Inventor · disambiguated record
Maurizio Chiriva-Internati
Also filed as: CHIRIVA-INTERNATI MAURIZIO
7 granted patents·18 pending applications·27 citations·filing 2002–2021
81Inventor score
Files withUNIV TEXAS TECH SYSTEM9KIROMIC LLC6KIROMIC BIOPHARMA INC5CHIRIVA-INTERNATI MAURIZIO2ALBANY MEDICAL COLLEGE1
Top patents by PatentIndex Score
25 records- 0189US9970937B2Composition and method for diagnosis and immunotherapy of prostate cancerUNIV TEXAS TECH SYSTEM·Filed 2015·Granted May 15, 2018·5 cites·6 claims
- 0281US9272014B2Galectin-3C combination therapy for human cancerCHIRIVA-INTERNATI MAURIZIO·Filed 2012·Granted Mar 1, 2016·5 cites·13 claims
- 0381US9062349B2Composition and method for diagnosis and immunotherapy of prostate cancerCHIRIVA-INTERNATI MAURIZIO·Filed 2012·Granted Jun 23, 2015·7 cites·8 claims
- 0474US7405077B2Sperm protein 17 for the diagnosis and treatment of cancerALBANY MEDICAL COLLEGE·Filed 2002·Granted Jul 29, 2008·9 cites·1 claims
- 0572US9744212B2Galectin-3C combination therapy for human cancerUNIV TEXAS TECH SYSTEM·Filed 2016·Granted Aug 29, 2017·1 cites·19 claims
- 0655US9518989B2Composition and method for diagnosis and immunotherapy of lung cancerUNIV TEXAS TECH SYSTEM·Filed 2014·Granted Dec 13, 2016·0 cites·8 claims
- 0748US2024293544A1Mesothelin isoform binding molecules and chimeric pd1 receptor molecules, cells containing the same and uses thereofKIROMIC BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 0848US2022310200A1Methods for identifying and using disease-associated antigensKIROMIC BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 0946US2023420077A1Disease-associated isoform identifierKIROMIC BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 1045US2024279353A1Mesothelin isoform binding molecules and chimeric pd1 receptor molecules, cells containing the same and uses thereofKIROMIC BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 1143US2017080071A1Composition and Method for Diagnosis and Immunotherapy of Lung CancerUNIV TEXAS TECH SYSTEM·Filed 2016·Application pending·0 cites
- 1242US2015098925A1Compositions and methods for treating cardiovascular diseases using disease-specific promoterKIROMIC LLC·Filed 2014·Application pending·0 cites
- 1341US10717774B2Compositions and methods for treating cancersKIROMIC INC·Filed 2017·Granted Jul 21, 2020·0 cites·5 claims
- 1438US2016030539A1Cancer testis antigen sperm protein 17 as a target for breast cancer immunotherapy and diagnosisUNIV TEXAS TECH SYSTEM·Filed 2015·Application pending·0 cites
- 1538US2016122408A1Galectin-3 Inhibitor (Gal-3M) is Associated with Additive Anti-Myeloma and Anti-Solid Tumor Effects, Decreased Osteoclastogenesis and Organ Protection when Used in Combination with Proteasome InhibitorsUNIV TEXAS TECH SYSTEM·Filed 2016·Application pending·0 cites
- 1638US2017044223A1Human Sperm Fibrous Sheath (FS) Proteins: New Target Antigens For Use In Therapeutic Cancer Vaccines And Diagnostic Screening And Methods Of Using SameKIROMIC LLC·Filed 2016·Application pending·0 cites
- 1738US2016122407A1Galectin-3 Inhibitor (Gal-3M) is Associated with Additive Anti-Myeloma and Anti-Solid Tumor Effects, Decreased Osteoclastogenesis and Organ Protection when Used in Combination with Proteasome InhibitorsUNIV TEXAS TECH SYSTEM·Filed 2016·Application pending·0 cites
- 1836US2015216999A1Compositions and methods for treating cardiovascular diseases using smad3KIROMIC LLC·Filed 2015·Application pending·0 cites
- 1936US2015335679A1Methods and Compositions for Treating Malignancies with Dendritic CellsKIROMIC LLC·Filed 2015·Application pending·0 cites
- 2036US2016263247A1Compositions and methods for treating cardiovascular diseases using foxp3KIROMIC LLC·Filed 2016·Application pending·0 cites
- 2135US2015216931A1Galectin-3 inhibitor (gal-3m) is associated with additive anti-myeloma and anti-solid tumor effects, decreased osteoclastogenesis and organ protection when used in combination with proteasome inhibitorsUNIV TEXAS TECH SYSTEM·Filed 2015·Application pending·0 cites
- 2235US2015157691A1Galectin-3 to Treat Ovarian CancerUNIV TEXAS TECH SYSTEM·Filed 2014·Application pending·0 cites
- 2334US2015110897A1Sperm Protein as a Detection Biomarker of Early Stage Ovarian CancerKAST WIJBE MARTIN·Filed 2012·Application pending·0 cites
- 2428US2017122949A1Diagnosis and treatment of ciliated hepatic foregut cystsKIROMIC LLC·Filed 2015·Application pending·0 cites
- 2527US2017307621A1Platform for the identification of tumor-associated cancer/testes antigensKIROMIC BIOPHARMA INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Maurizio Chiriva-Internati files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →